HSBC HOLDINGS PLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$45,569
+5.4%
75,8480.0%0.00%
Q2 2023$43,249
-23.7%
75,848
-7.2%
0.00%
Q1 2023$56,670
-76.8%
81,704
-26.3%
0.00%
Q4 2022$244,530
-7.0%
110,900
+37.5%
0.00%
Q3 2022$263,000
+62.3%
80,667
+88.2%
0.00%
Q2 2022$162,000
+36.1%
42,858
+95.7%
0.00%
Q1 2022$119,000
-47.6%
21,895
+32.2%
0.00%
Q4 2021$227,000
-44.6%
16,568
-30.1%
0.00%
Q2 2021$410,000
+26.9%
23,712
+22.6%
0.00%
-100.0%
Q3 2020$323,000
-14.3%
19,334
+18.7%
0.00%0.0%
Q2 2020$377,000
-69.4%
16,287
-75.9%
0.00%
-50.0%
Q3 2019$1,233,000
-54.4%
67,643
-11.1%
0.00%
-60.0%
Q2 2019$2,706,000
+16.4%
76,050
+9.9%
0.01%
+25.0%
Q1 2019$2,324,000
+42.4%
69,171
+39.3%
0.00%
+33.3%
Q4 2018$1,632,000
-57.5%
49,656
-22.3%
0.00%
-50.0%
Q3 2018$3,841,000
+39.3%
63,916
+13.1%
0.01%
+20.0%
Q2 2018$2,758,000
-82.6%
56,499
-62.1%
0.01%
-79.2%
Q1 2018$15,828,000
+4272.4%
148,960
+404.7%
0.02%
+2300.0%
Q4 2016$362,000
+162.3%
29,512
+167.4%
0.00%
Q2 2015$138,000
+14.0%
11,035
+0.7%
0.00%
Q1 2015$121,000
-33.5%
10,959
-6.4%
0.00%
Q4 2014$182,00011,7140.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2020
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 508,000$6,132,0001.80%
Bodri Capital Management, LLC 250,000$3,018,0001.46%
Granahan Investment Management 3,442,980$41,557,0001.28%
TIRSCHWELL & LOEWY INC 603,441$7,284,0001.22%
NEA Management Company, LLC 1,825,600$22,035,0001.12%
Cormorant Asset Management, LP 450,000$5,432,0001.12%
HARVEY CAPITAL MANAGEMENT INC 221,750$2,676,0001.05%
Cheyne Capital Management (UK) LLP 229,577$2,772,0000.99%
Artal Group S.A. 1,650,000$19,916,0000.73%
FIC CAPITAL INC 147,293$1,778,0000.71%
View complete list of NEKTAR THERAPEUTICS shareholders